A Dose Ascending Study to Evaluate the Safety of NH002 as a Contrast Agent in Cardiac Echocardiography
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Cardiac Disease
- Type
- Interventional
- Phase
- Phase 1Phase 2
- Design
- Allocation: N/AIntervention Model: Sequential AssignmentMasking: None (Open Label)Masking Description: The reviewer of echocardiograms in this trial is blinded to the treatment assignments and subject identifiers.Primary Purpose: Diagnostic
Participation Requirements
- Age
- Between 20 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04185246
- Collaborators
- StatPlus,Inc.
- Investigators
- Principal Investigator: Wen-Chung Yu Taipei Veterans General Hospital, Taiwan
Get Well Soon